ANGIODEVICE INTERNATIONAL GMBH
Patent Owner
Stats
- 29 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 31, 2013 most recent publication
Details
- 29 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,518 Total Citation Count
- Nov 14, 1989 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8481073 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and useOct 24, 11Jul 09, 13[A61K, A61F]
8460708 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and useOct 24, 11Jun 11, 13[A61K]
8197802 Method for treating or inhibiting the formation of adhesions following surgery or injuryDec 28, 10Jun 12, 12[A61K, C08G, A61B]
8067031 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and useApr 28, 05Nov 29, 11[A61K]
7883693 Compositions and systems for forming crosslinked biomaterials and methods of preparation of useJan 31, 06Feb 08, 11[A61K]
7883694 Method for preventing the formation of adhesions following surgery or injuryJan 27, 04Feb 08, 11[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0159,075 COMPOSITIONS AND SYSTEMS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USEAbandonedDec 27, 10Jun 30, 11[A61K, A61F]
2004/0186,231 Dehydrated, shaped matrix and use thereof in the treatment of vascular malformationAbandonedJan 27, 04Sep 23, 04[C08G]
5643464 Process for preparing a sterile, dry crosslinking agentExpiredJun 30, 95Jul 01, 97[A01N, A61F, B01J]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
